Skip to main content

What the FDA labels say about taking them together

Captopril and furosemide

Captopril's FDA label of February 6, 2026 names furosemide in its drug interactions section; furosemide's label does not name captopril itself but warns about its class (ACE inhibitors).

Check it at the source: the captopril FDA label on DailyMed (effective February 6, 2026, AiPing Pharmaceutical, Inc.); the furosemide FDA label on DailyMed (effective September 30, 2025, Validus Pharmaceuticals LLC).

What does the captopril label say about furosemide?

Captopril label, drug interactions

Loop Diuretics: Furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients.

Source: FDA drug label (Captopril), AiPing Pharmaceutical, Inc., effective February 6, 2026 (SPL set 3b789f16-b291-4012-be39-af3beec3ff9a), via openFDA; the full label on DailyMed

What does the furosemide label say about captopril?

Furosemide's label does not name captopril itself; it warns about its class (ACE inhibitors):

Furosemide label, drug interactions

LASIX combined with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may lead to severe hypotension and deterioration in renal function, including renal failure.

Furosemide label, drug interactions

An interruption or reduction in the dosage of LASIX, angiotensin-converting enzyme inhibitors, or angiotensin receptor blockers may be necessary.

Source: FDA drug label (Lasix), Validus Pharmaceuticals LLC, effective September 30, 2025 (SPL set 2c9b4d8f-0770-482d-a9e6-9c616a440b1a), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

13Captopril generic labelers
52Furosemide generic labelers
CaptoprilFurosemide
Labeled forHigh blood pressure, Heart failure, Chronic kidney diseaseHeart failure, High blood pressure, Edema (fluid retention)
Boxed warningYesNo
Pharmacy cost (NADAC)$0.228 per tablet 12.5 mg tablet$0.490 per mL 20 mg/2 mL vial
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?